COVID-19: A Brief Overview of the Discovery Clinical Trial

  • Pharmaceuticals (Basel). 2020 Apr 10;13(4):65. doi: 10.3390/ph13040065.
Jean Jacques Vanden Eynde  1
Affiliations
  • 1. Formerly head of the Department of Organic Chemistry (FS), University of Mons-UMONS, 7000 Mons, Belgium.
PMID: 32290348 DOI: 10.3390/ph13040065
Abstract

The outbreak of COVID-19 is leading to a tremendous search for curative treatments. The urgency of the situation favors a repurposing of active drugs but not only antivirals. This short communication focuses on four treatments recommended by WHO and included in the first clinical trial of the European Discovery project.

Keywords
COVID-19; SARS-CoV-2; chloroquine; hydroxychloroquine; lopinavir/ritonavir; remdesivir; repurposing.
Products